Archives For January 2016

By 1986, the biotech industry had taken a firm footing in the minds (and pockets) of the financial community and its to-be-iconic annual gathering, now called the J.P. Morgan Healthcare Conference (then called Hambrecht & Quist or H&Q), had convened the biotech market makers for the fifth time. The energy was high. Since the 1980 IPO of Genetech, the industry’s iconic poster child, 41 subsequent companies had found their way onto the public stock markets, including companies such as Biogen, Immunex, Amgen, Chiron, and Scios (then known as Cal Bio), among others.

Continue Reading...